Paper34770992
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis.
Crocetti L and 10 others. Molecules, 2021. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis. Papers, record 34770992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34770992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Pyridines | Major topic |
| Receptors, Formyl Peptide | Major topic |
| Administration, Oral | |
| Animals | |
| Freund's Adjuvant | |
| Humans | |
| Male | |
| Molecular Structure | |
| Rats | |
| Rats, Sprague-Dawley | |
| Tumor Cells, Cultured |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM115371 | National Institutes of Health (NIH) IDeA Program Grants | PubMed | ||
| GM103474 | National Institutes of Health (NIH) IDeA Program Grants | PubMed | ||
| project 1009546 | USDA National Institute of Food and Agriculture Hatch | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27541263 | Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study. | Eur J Med Chem | 2016 | https://conductscience.org/library/papers/27541263 | PubMed |
| 2 | 17267386 | Resolution of inflammation: state of the art, definitions and terms. | FASEB J | 2007 | https://conductscience.org/library/papers/17267386 | PubMed |
| 3 | 32388428 | Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis. | Bioorg Chem | 2020 | https://conductscience.org/library/papers/32388428 | PubMed |
| 4 | 27134116 | 2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. | Bioorg Med Chem | 2016 | https://conductscience.org/library/papers/27134116 | PubMed |
| 5 | 24824742 | A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24824742 | PubMed |
| 6 | 27859446 | Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists. | Drug Dev Res | 2017 | https://conductscience.org/library/papers/27859446 | PubMed |
| 7 | 17306548 | N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor. | Bioorg Med Chem | 2007 | https://conductscience.org/library/papers/17306548 | PubMed |
| 8 | 33493655 | Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33493655 | PubMed |
| 9 | 29879657 | Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis. | Int Immunopharmacol | 2018 | https://conductscience.org/library/papers/29879657 | PubMed |
| 10 | 28186109 | Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? | Sci Rep | 2017 | https://conductscience.org/library/papers/28186109 | PubMed |
| 11 | 26478210 | Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. | Trends Pharmacol Sci | 2015 | https://conductscience.org/library/papers/26478210 | PubMed |
| 12 | 23744588 | Synthesis, HPLC enantioresolution, and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists. | Chirality | 2013 | https://conductscience.org/library/papers/23744588 | PubMed |
| 13 | 27713514 | Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: relevance of nicotinic receptors. | Sci Rep | 2016 | https://conductscience.org/library/papers/27713514 | PubMed |
| 14 | 30784067 | Intra-articular mucilages: behavioural and histological evaluations for a new model of articular pain. | J Pharm Pharmacol | 2019 | https://conductscience.org/library/papers/30784067 | PubMed |
| 15 | 16697190 | Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. | Bioorg Med Chem Lett | 2006 | https://conductscience.org/library/papers/16697190 | PubMed |
| 16 | 29424301 | Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors. | Curr Med Chem | 2019 | https://conductscience.org/library/papers/29424301 | PubMed |
| 17 | 31336833 | Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31336833 | PubMed |
| 18 | 23747022 | Resolution phase lipid mediators of inflammation: agonists of resolution. | Curr Opin Pharmacol | 2013 | https://conductscience.org/library/papers/23747022 | PubMed |
| 19 | 32060286 | Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling. | Nat Commun | 2020 | https://conductscience.org/library/papers/32060286 | PubMed |
| 20 | 19498085 | International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. | Pharmacol Rev | 2009 | https://conductscience.org/library/papers/19498085 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40069490 | Oral FPR2/ALX modulators tune myeloid cell activity to ameliorate mucosal inflammation in inflammatory bowel disease. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40069490 | PubMed |
| 38799342 | Trans-Chalcone (1-3-diphenyl-2-propen-1-one) as a Therapeutic Candidate in Joint Inflammation via Reduction of TNF-α, IL-1β, IL-6, and IL-17 in Rodents: An In Vivo Study by RT-PCR and ELISA analysis. | ACS Omega | 2024 | https://conductscience.org/library/papers/38799342 | PubMed |
| 37371936 | Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37371936 | PubMed |
| 36440821 | Formyl peptide receptors in bone research. | Connect Tissue Res | 2023 | https://conductscience.org/library/papers/36440821 | PubMed |
| 35744876 | Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity. | Molecules | 2022 | https://conductscience.org/library/papers/35744876 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FPR1 | 2357 | PubTator's text mining | https://conductscience.org/library/genes/2357 | NCBI Gene |
| FPR2 | 2358 | PubTator's text mining | https://conductscience.org/library/genes/2358 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34770992
GET https://conductscience.org/api/papers/v1/34770992/references?page=2